Clinical investigation of medicinal products for the treatment of multiple sclerosis

Current effective version

PDF iconRevision 2 - Adopted guideline

Reference numberCHMP/771815/2011 Rev. 2
Effective from01/10/2015
KeywordsMultiple sclerosis, neurological disease
DescriptionThis document provides guidance on the evaluation of medicinal products for the treatment of multiple sclerosis. It primarily focuses on treatments aimed to modify disease progression. In addition it concerns the treatment of relapses, repair and restoration of functioning and symptomatic improvement.

Document history

Revision 2

Current version

PDF iconAdopted guideline

PDF iconDraft guideline

PDF iconConcept paper

In operation: 01/10/2015–present

Published: 09/10/2012

Published: 08/07/2011

Revision 1

PDF iconAdopted guideline

PDF iconOverview of comments

PDF iconDraft guideline

In operation: 01/06/2007–30/09/2015

Published: 16/11/2006

Published: 15/09/2005

Related content

How useful was this page?

Add your rating